Colin Green holds the W&B Hadden Chair in Ophthalmology and Translational Vision Research in the Department of Ophthalmology at the University of Auckland. Professor Green’s group focuses on cell reprogramming and connexin channel roles in disease, in particular chronic inflammatory diseases such as those affecting the retina. He has co-authored 185 manuscripts and book chapters and is a named inventor on over 255 patents in 29 patent families. He is a co-founder of CoDa Therapeutics (Auckland, NZ) and OcuNexus Therapeutics (US).


W3 Total Cache is currently running in Pro version Development mode.